Owkin affiliate company Epkin recently started the phase 1 INVOKE clinical trial of the first drug to be developed using Owkin K – a first-in-class EP2/EP4/DP1 triple inhibitor codenamed OKN4395 ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

The Consolidated Commission on Utilities on Tuesday approved an up to $7.14 million contract to deal with a potentially harmful insecticide in three Guam Waterworks Authority wells.

Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor technology for use in clinical trials and patient monitoring.